Unicycive Therapeutics, Inc. (UNCY)
7.60
+0.22
(+2.98%)
USD |
NASDAQ |
Jun 01, 16:00
7.80
+0.20
(+2.63%)
After-Hours: 19:52
Unicycive Therapeutics EPS Diluted (Quarterly) : -0.5363 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.0211 |
| Gilead Sciences, Inc. | 1.612 |
| Alnylam Pharmaceuticals, Inc. | 1.508 |
| Anika Therapeutics, Inc. | -0.3737 |
| Savara, Inc. | -0.1472 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -12.82M |
| Total Expenses (Quarterly) | 12.82M |
| Enterprise Value | 143.40M |
| Earnings Yield | -27.06% |
| Normalized Earnings Yield | -22.81 |